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INTRODUCTION 
 
Posterior urethral valve represents the most common cause 
of congenital obstructive uropathy leading to childhood renal 
failure. The incidence of posterior urethral valve is approximately 
1:5000 to 1:8000 infant males. Challenges faced by children with 
posterior urethral valve are multiple. Obstruction by valve is the 
process which involves the entire urinary system. Appropriate 
clinical suspicion remains the key to diagnosis which is confirmed 
by standard imaging techniques. The risk of renal compromise and 
ultimate renal failure is a potential problem for each patient. The 
outcome may be altered by appropriate intervention, but in most 
cases the renal development in utero determines the need for 
eventual dialysis or transplantation. 
 
The prognosis for children with urethral valves is improving 
and current management is gradually rewriting the historical data. 
In most modern large series neonatal deaths make upto only 2% 
to 3% of the series. 
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Early (prenatal) recognition, control of infection, appropriate 
and selective surgery recognition of harmful urodynamic 
abnormalities, modern nephrologic management and eventual 
dialysis and transplantation all combine to increase survival now to 
an extent unheard of in the past. 
 
In the past, the treatment of posterior urethral valve was 
based primarily on the mechanism of obstruction and its relief. The 
current treatment of this condition is based upon our evolving 
knowledge of the consequences of bladder outlet obstruction. So, 
the quality of life in these patients, are very much improving in the 
recent days.  
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AIMS OF THE STUDY 
 
• To analyze the various described prognostic factors, in our 
antenatally diagnosed patients. 
• To determine the prognostic factors that predict the outcome 
of posterior urethral valve patients postnatally.  
• To identify the significant of the each individual factor in the 
long term outcome. 
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MATERIALS AND METHODS 
 
Study Type : Retrospective and prospective study 
Study period : January 2004 to December 2009 
Study centre : Coimbatore Medical College and Hospital,  
Coimbatore – 18. 
 
5 
 
METHODOLOGY 
 
In our study, we registered 52 cases of posterior urethral 
valves out of which 7 cases are antenatally diagnosed, 24 cases 
were in the new born period, 13 cases were between 1 to 12 
months of age group, 8 cases were between 1 to 4 years of age 
group.  
 
The initial diagnosis or suspicion of posterior urethral valve 
based on prenatal ultrasonagraphy, UTI, or others (dehydration, 
electrolyte changes, palpable bladder, etc.)  
 
The patient’s initial evaluation included renal function, urine 
culture, urine analysis upper and lower urinary tract 
ultrasonagraphy and MCUG. 
      
Among the 52 patients, 43 patients were treated by primary 
cystoscopic valve ablation and the remaining cases underwent 
urinary diversion either vesicostomy (6 cases) or cutaneous 
ureterostomy. 
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All the above patients were evaluated regularly throughout 
their follow-up and accessing the renal function, urine culture and 
urine analysis; upper and lower urinary tract ultrasonagraphy, 
MCUG and DMSA scan. The results were analyzed.  
 
Our follow up protocols are 
• Accessing the regular stream of urine post operatively, 
• Monthly urine for culture and sensitivity 
• MCUG after 6 months,  
• Ultrasound KUB to assess the upper and lower urinary tract 
• DMSA scan in needed patients.  
 The results were analyzed 
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RESULTS 
 
Age distribution 
Age Group No. of patients Percentage 
New born 13 25 
1 – 12 months 31 59.62 
1 – 4 years 8 15.38 
Total 52 100 
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Presentation 
Presentation No. of patients Percentage 
Antenatally diagnosed 7 13.46 
Voiding symptoms 20 38.46 
UTI 21 40.38 
SEPSIS 4 7.70 
Total 52 100 
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Antenatally diagnosed cases 
Expired  2 
Lost to follow up 2 
Primary fulguration 3 
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Initial evaluation 
Elevated renal parameters 20 
Recurrent UTI 17 
Increased echogenecity of kidney or altered CMD 12 
Urosepsis 3 
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Associated Anomalies 
Uretrocele 1 
Bilateral UDT 2 
Urachal Cyst 1 
Seizure disorder 1 
Epididymo orchitis 2 
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Treatment 
Treatment No. of patients Percentage 
Primary valve ablation 43 82.70 
Vesicostomy 6 11.54 
Cutanous uretrostomy 3 5.76 
Total 52 100 
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Follow up 
Follow up No. of patients Percentage
Fully continent on regular follow-up 12 23.08 
Refulguration 6 11.53 
Chronic renal failure 10 19.23 
Recurrent UTI 10 19.23 
Secondary Surgical procedures 9 17.31 
Expired 5 9.62 
Total 52 100 
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Pressure  Pop Off mechanisms 
Mechanisms No. of patients Percentage 
VURD 7 53.85 
Patent uracus 1 7.69 
Bladder Divaticulam 5 38.46 
Total 13 100 
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REVIEW OF LITERATURE 
 
ANATOMY 
In 1919, Hugh Hampton Young and his associates published 
their historic description of PUV. He described three type of 
posterior urethral valve31. 
 
Young classification is,  
• Type I valves, which lie as fins of mucosal tissue that radiate 
from the urethral crest of the distal verumontanum and 
sweep across the urethral lumen to fuse anteriorly.  
• Type III valves are obstructing diaphragms that lie in a 
transverse plane to the urethral lumen and originate distal to 
the verumontanum, near the   bulbomembranous junction.  
• Type II valves, rarely mentioned in the literature, are mucosal 
folds that radiate from the proximal aspect of the 
verumontanum and extend cephalad to the bladder neck. 
 
In an attempt to provide a simple yet anatomically correct 
nomenclature for these lesions, Dewan and coworkers advocated 
replacing the complex Young classification with the unifying 
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terminology congenital obstructing posterior urethral 
membranes (COPUM). 
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POSTERIOR URETHRAL VALVES 
 
PRIMARY VALVE ABLATION 
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ETIOLOGY 
 
The exact etiology of PUV or membranes has never been 
established2. The prostatic urethra develops from the urogenital 
sinus by the 8th week of gestational life. The mesonephric ducts 
and paramesonephric ducts are both absorbed in this region of the 
vesicourethral canal. The mesonephric ducts develop into the 
ductus deferens, with the openings (ejaculatory ducts) lying lateral 
to the verumontanum. The distal paramesonephric ducts form part 
of the prostatic utricle, a small diverticulum on the verumontanum. 
The colliculus seminalis or verumontanum forms on the dorsal 
floor of the prostatic urethra as a result of the elevation of the 
urethral wall by the expanding ejaculatory ducts and utricle. The 
ends of the wolffian ducts form the normal urethral crest as they 
migrate cranially from an anterolateral position in the internal 
cloaca to a posterior position at the verumontanum. 
 
 Stephens and associates hypothesized3 that the wolffian 
duct orifices in valve patients are initially misplaced and integrate 
abnormally into the urethral wall to form the obstructing lesion. 
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RENAL PATHOLOGY AND URETHRAL VALVES 
 
Renal insufficiency associated with congenital urethral 
obstruction may result from either primary renal dysplasia or 
progressive renal deterioration after birth. Experimental models 
and clinical cases demonstrate the pathogenesis of renal dysplasia 
associated with urethral obstruction. Severe obstruction in utero 
has been theorized to transmit damaging back-pressure to the 
upper tracts, thereby causing deformation of the developing 
nephrons. Animal data suggest that early obstruction may result in 
severe upper tract changes4.  
 
Fetal lamb studies showed that early second-trimester 
ureteral obstruction resulted in renal dysplasia similar to that seen 
with severe PUV. Similarly, Beck’s experimental work in fetal 
sheep demonstrated dysplasia occurring with early obstruction, 
whereas later in utero obstruction resulted only in hydronephrosis.  
 
Henneberry and Stephens5 supported a competing 
hypothesis known as the “bud theory” of renal dysplasia. They 
suggested that aberrant caudal budding of the ureter from the 
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mesonephric duct causes aberrant induction of the renal 
mesenchyme. In support of this theory6, they examined 34 renal 
units from autopsies of valve patients, with 14 of the 19 patients 
being younger than 6 months of age. They found a significant 
positive correlation between lateral trigone placement of the 
ureteral orifice and the gross renal morphologic changes of 
hydronephrosis and parenchymal thinning.  
 
Histologic evaluation demonstrated lower mean glomerular 
counts and the most severe degree of dysplasia in renal units with 
the most lateral ureteral placement. Nevertheless, four renal units 
with grossly dilated and tortuous ureters demonstrated normal 
parenchymal development7. This finding suggests that the 
obstruction in these cases may have occurred later in gestation 
and provides evidence that backpressure and VUR alone are not 
responsible for dysplasia.  
 
The observation of poor function in the refluxing unit of 
patients with PUV seems to be very common, more so than in 
patients who have high-grade reflux without urethral obstruction. 
This may indicate overlapping pathologies, namely that in utero 
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pressure work combined with primary dysmorphism results in 
dysplasia and poor function. There are limited clinical 
histopathologic data in the literature demonstrating the renal 
damage associated with urethral obstruction.  
 
A series of renal biopsies8 from valve patients with renal 
insufficiency and reflux demonstrated histologic changes of 
obstruction in 60%, dysplasia in 25%, interstitial fibrosis in 25%, 
and infectious change in 15%.The authors contended that the 
relatively low incidence of primary dysplasia in their series 
provided support to the practice of supravesical urinary diversion. 
However, the patients studied were not newborns, so these 
findings may reflect secondary or developmental influences. 
 
In contrast, Tietjen8 and associates reported renal dysplasia 
in 85% of renal units from babies treated by proximal diversion for 
renal insufficiency at birth. Daikha-Dahmane9 and co-workers 
analyzed kidney lesions from fetuses demonstrating bilateral 
urinary tract obstruction and surviving 14 to 37 weeks’ gestation. 
All fetuses older than 20 weeks’ gestation showed renal dysplasia 
with blastema cells, interstitial fibrosis, and an arrest of 
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nephrogenesis. These findings support the irreversibility of 
obstructive changes occurring early in gestation. 
 
PRESSURE POP-OFF MECHANISMS IN URETHRAL 
OBSTRUCTION 
Hoover and Duckett introduced the concept of pressure 
popoffs in the obstructed urinary tract in 1982. They noted 
preserved contralateral renal function in patients with unilateral 
reflux into a nonfunctioning kidney. This phenomenon, known as 
the valves, unilateral reflux, and renal dysplasia (VURD) 
syndrome, suggests that mechanisms that relieve bladder 
pressure may have a protective effect on renal function.  
 
In addition to VUR, other less common pop-off mechanisms 
include large bladder diverticula, bladder rupture with urinary 
ascites, and renal urinary extravasation with urinoma formation. 
There is growing evidence that decompressive mechanisms may 
also affect bladder development. If the bladder is protected from 
pressure work during development, can its morphology and 
function be preserved?9  Chen and associates presented unusual 
documentation of three different pop-off mechanisms in a surviving 
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infant with severe PUV. In their patient, oligohydramnios, bladder 
dome perforation, and ascites were diagnosed at 26 weeks’ 
gestation. At 37 weeks’ gestation, bilateral urinomas developed.  
 
Postnatal evaluation revealed bilateral VUR and a small, 
dystrophic bladder, but there was no long-term follow-up of bladder 
function. Kaefer10 and colleagues reported favorable bladder 
outcomes in 87% of valve patients with pop-off mechanisms. 
Rather than the typical thick-walled, trabeculated bladder, patients 
with upper tract pop-off mechanisms may demonstrate a 
smoothwalled bladder on voiding cystourethrography (VCUG). 
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PRENATAL DIAGNOSIS OF URETHRAL OBSTRUCTION 
In the developed countries where obstetric sonography is 
routinely performed, most fetuses with urinary tract dilation are 
detected prenatally. The sensitivity for detection of obstructive 
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uropathy by prenatal ultrasonography in multiple series was 
between 90% and 100%.11  Prenatal ultrasonography should 
specifically address renal pelvic anteroposterior diameter, amniotic 
fluid volume, renal echogenicity, renal cortex thickness, bladder 
distention, bladder wall thickness, presence of urethral dilation, 
and evidence of urachal patency.  
 
Fetal genitourinary tract screening by ultrasound is possible 
at 20 weeks’ gestation, at which time the kidney is of adequate 
size for evaluation.12 A renal pelvic diameter between 4 and 10 
mm in the second trimester is considered to represent mild dilation 
and does not persist postnatally in 97% of cases. A diameter 
exceeding 10 mm, or the presence of dilated calyces with a pelvic 
diameter of less than 10 mm, suggests significant pathology and 
warrants postnatal follow-up.  
 
The fetal renal parenchyma should be evaluated for 
thickness and echogenicity. Renal cortical echogenicity equal to 
that of the adjacent liver can occur in infants less than 4 months of 
age with normal kidneys. Echogenicity brighter than liver or spleen 
denotes underlying renal pathology. Cortical cysts in a brightly 
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echogenic kidney are an unmistakable indication of primary renal 
dysplasia. Cortical atrophy can be seen in association with 
hydronephrosis and is defined as fetal renal cortex less than 2 mm 
in thickness. The fetal bladder is more difficult to assess by 
ultrasonography.13  
 
By definition, the bladder wall is considered thickened if it is 
visible when the bladder is full. Amniotic fluid volume is a key 
feature of the fetal ultrasound study.  If hydroureteronephrosis and 
persistent bladder dilation are found together, the diagnosis of 
PUV is suspected, although similar findings may be found in 
patients with prune-belly syndrome, primary megaureter, or VUR. 
Of fetuses monitored for persistent megacystis and 
hydronephrosis suggestive for valves, 42% to 48% had confirmed 
posterior urethral obstruction at postnatal diagnosis.14 The findings 
of increased renal echogenicity and oligohydramnios in addition to 
hydronephrosis and bladder dilation greatly increase the predictive 
value of prenatal ultrasonography.  
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POSTNATAL DIAGNOSIS OF URETHRAL OBSTRUCTION 
All newborn males with a history of significant prenatal 
hydronephrosis should be evaluated for possible urethral 
obstruction. Because volume depletion is common in the first 48 
hours of life, ultrasound studies obtained during this period can be 
falsely negative and should be repeated at 1 week of age.  
 
The more severe cases of obstruction typically show 
hydroureteronephrosis, even with relative volume depletion.  
 
A common misconception is that normal voiding guarantees 
a normal urethra.15  Although some infants with obstruction have 
palpable bladder distention or delayed voiding, others have a 
normal physical examination and regularly wet diapers. A VCUG 
should be considered before discharge from the nursery if any 
significant degree of renal collecting system dilation is present on 
prenatal ultrasonography. In the infant without prenatal renal 
imaging, severe urethral obstruction can manifest as abdominal 
distention from a large full bladder, massive 
hydroureteronephrosis, or urinary ascites. Patent urachus and 
retroperitoneal urinoma are other findings that raise the suspicion 
of bladder outlet obstruction.   
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Newborns with bladder outlet obstruction also present with 
respiratory distress secondary to pulmonary hypoplasia, severe 
abdominal distention, or pneumothorax. Other infants with PUV 
may have a delayed diagnosis made after workup for urinary tract 
infection, sepsis, acute renal failure, or failure  to thrive in the first 
months of life.  The VCUG remains the “gold standard” for 
postnatal diagnosis of PUV. Transperitoneal ultrasonography is 
reported to be an alternative diagnostic tool that can demonstrate 
the urethral changes seen with PUV.  
 
TREATMENT IN THE NEWBORN 
The initial treatment in a newborn diagnosed with PUV 
should begin with bladder drainage by urethral catheter, antibiotic 
administration, and correction of fluid and electrolyte abnormalities. 
Creatinine measurements during the first days of life reflect the 
maternal levels and are not indicative of the infant’s  renal function. 
Serial creatinine measurements taken 7 to 10  days after bladder 
drainage establish the newborn preoperative nadir in full-term 
infants. 
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 After this initial period of stabilization, most infants can 
safely undergo primary ablation of valves. Endoscopic Valve 
Ablation in the Newborn New pediatric endoscopic equipment has 
drastically changed the surgical approach to valve treatment.  The 
8.5F resectoscope with a 5-degree lens and cold knife hook 
working element can be employed in infants as small as 2000 g.37 
Although some surgeons continue to prefer to incise the valves 
with a Bugbee ball–tipped electrode. 
 
A Bugbee electrode passed through the working channel of a 
5F cystourethroscope is a useful technique in very small infants 
whose urethras cannot accommodate the larger instruments. 24 
Potassium-titanyl-phosphate (KTP) laser valve ablation has been 
reported to be safe in newborn infants, with no urethral stricture 
formation at 3 years’ follow-up; incontinence was not addressed in 
this study. 
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 Management after Valve Ablation 
A common concern of pediatricians managing the patient 
with PUV is the persistence of severe hydroureteronephrosis after 
valve ablation.17 Frequently, this is interpreted as evidence of 
ureterovesical junction obstruction, and, when it is combined with 
elevated creatinine levels, it leads to supravesical diversion  in 
some institutions. Chronic dilation of the collecting system and 
ureters from in utero obstruction or reflux does not resolve 
immediately but is usually not evidence of continued high 
intrarenal pressure.  
 
Tietjen18 and associates used the Whitaker test to 
demonstrate fixed ureterovesical junction obstruction in only 4% of 
renal units in valve patients who had undergone proximal urinary 
diversion for newborn renal insufficiency. Furthermore, primary 
renal dysplasia was identified by biopsy in 85% of these patients. 
The fact that more than 40% of these patients progressed to end-
stage renal failure with proximal diversion supports the belief that 
renal insufficiency demonstrated after newborn creatinine level 
stabilization is caused by underlying primary renal dysplasia and is 
not the result of continued obstruction.   
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AUGMENTATION (URETEROCYSTOPLASTY) 
WITH MITROFANOFF PROCEDURE 
 
 
NIGHT DRAINAGE 
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Vigilant follow-up18 is essential in the neonatal period after 
hospital discharge. Persistent hydroureteronephrosis is common 
but should be closely monitored. Urodynamic evaluation can 
confirm that resting bladder pressures are in a safe range (<30 cm 
H2O) and are not the cause of persistent hydronephrosis.  
Ultrasonography is also used to evaluate the renal parenchymal 
echogenicity and to demonstrate the presence of corticomedullary 
junctions. Hulbert and colleagues19 found that distinct 
corticomedullary differentiation in infants with PUV imaged before 
6 months of age reliably predicted serum creatinine levels lower 
than 0.8 mg/dl at follow-up 1 to 4 years later. 
 
Although the obstructive effects on the prostatic urethra and 
bladder neck do not resolve immediately, a postoperative VCUG 
should confirm complete valve ablation. In cases of severe 
preoperative urethral distortion, some surgeons prefer to perform 
repeat cystourethroscopy to rule out and treat possible residual 
valve tissue.20  
 
A nuclear medicine renal scan is best obtained after 4 weeks 
of life to establish a baseline for differential renal function and to 
34 
 
identify nonfunctioning renal units. Cooperative management by 
pediatric urology and nephrology staff facilitates the medical 
management in these infants. Acidosis and salt-wasting 
nephropathy are common and necessitate frequent monitoring of 
serum electrolytes.  
 
Infants suffering the most severe degrees of obstruction 
typically do not survive in utero because of elective termination or 
fetal demise. If these infants do survive, the degree of renal 
dysplasia and bladder damage can be so severe that management 
must be tailored to allow their survival, with acceptance that both 
renal and bladder function are often unsalvageable.  
 
VESICOURETERAL REFLUX RESOLUTION AFTER PRIMARY 
VALVE ABLATION 
VUR occurs in up to 75% of infants diagnosed with PUV in 
the first year of life. Traditionally, routine management of these 
patients has included ureteral reimplantation, often done at the 
same time as contralateral nephroureterectomy of nonfunctioning 
renal units. There is long-standing evidence that reimplantation is 
not necessary in most valve patients, and conservative 
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management alone is safe and effective. In a series of infants 
treated by primary valve ablation alone, Close and coworkers 
found improvement in reflux grade in 18 of 19 refluxing renal units 
after 1 year.  
 
Complete resolution of reflux occurred within 2 years after 
valve ablation in 12 (86%) of 14 patients.22 Reflux into 
nonfunctioning kidneys typically does not resolve. 
Nephroureterectomy has been performed in the past to improve 
voiding dynamics in these patients, although ureteral preservation 
for possible ureterocystoplasty is appropriate in some cases. 
 
BLADDER FUNCTION IN VALVE PATIENTS 
There is wide acceptance of the concept that maximizing the 
long-term outcome in PUV patients centers on maintaining bladder 
function. Older patients with a missed diagnosis of severe PUV 
and valve patients with a history of urinary diversion were 
described by Mitchell in 1986 as illustrative cases of the “valve 
bladder syndrome.” 23, 24 
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For many, recognition of this syndrome has changed the 
approach to management of PUV in infants. Boys with a valve 
bladder demonstrate the long-term effect of persistent renal 
obstruction from high bladder pressures after relief of urethral 
obstruction. Pathologic changes in the entire urinary tract combine 
to further compromise renal function. 
 
Progressive hydroureteronephrosis, polydipsia, polyuria, 
urinary frequency, and enuresis with renal  insufficiency are 
hallmarks of the syndrome. Renal tubular dysfunction results in a 
severe urine concentrating defect with  polyuria and polydipsia. 
Urine production in these children can range from 3 to 6 L/day. In 
patients with VUR and grossly dilated upper tracts, ureteral 
peristalsis is poor, and large urine volumes result in incomplete 
emptying of the collecting system, ureters, and bladder. The thick-
walled valve bladder is poorly compliant and functionally lacks 
normal sensation. These patients learn to tolerate high intravesical 
pressures and are able to hold large urine volumes at these 
pressures without  pain. With gross distention, the thick wall of the 
bladder causes increased resistance to urine flow through the 
ureterovesical  junction.  
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Urine holding thus results in increased upper tract dilation 
and pressure and, ultimately, causes progressive  renal damage.  
There is an increasing focus on the role of the bladder in the long-
term outcome of patients with PUV. Urodynamic  patterns 
described in older valve patients include bladder hyperreflexia, 
hypertonia (noncompliance), and myogenic  failure.  
 
Although these changes are attributed to bladder outlet 
obstruction, the contribution of primary treatment to  dysfunction 
cannot be ascertained from such reports. Many of the studies of 
bladder and ureteral function in valve patients  are complicated by 
the inclusion of different primary treatment modalities and 
treatment ages in the same study group.  Studies have now been 
published that focus on the functional outcome in newborns 
undergoing primary ablation alone for the treatment of congenital 
urethral obstruction. Holmdahl and associates demonstrated 
normal bladder compliance by 1 year of age in all infants 
undergoing primary valve ablation at a mean age of less than 2 
months. They did not find the three dysfunctional patterns 
described by Peters and colleagues in older boys.  
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In a retrospective evaluation of 23 newborn infants treated by 
valve ablation in the first weeks and followed up from 1 to 9 years, 
Close and coworkers26, 27 & 28 found good bladder function as well 
as resolution  of upper tract abnormalities. VCUG performed 1 
year after valve resection showed resolution of trabeculation in 
more than 85% of patients. Additionally, when compared with 
infants treated by urinary diversion, those boys undergoing early 
valve ablation had significantly better bladder compliance and 
potty-training results.  
 
The mean bladder compliance was 17.2 mL/cm H2O in 
those infants treated by early primary incision, compared with 5.8 
mL/cm H2O in boys treated by diversion. Ninety-two percent of the 
boys undergoing early ablation were potty trained by 4 years of 
age, whereas only 17% of the diverted boys were dry by age 4. 
Low bladder compliance and high bladder pressures led to bladder 
augmentation in 3 (38%) of the 8 diverted patients. Only 1 (4%) of 
23 patients undergoing primary ablation required bladder 
augmentation, and that patient had severe urethral obstruction that 
was undetected until 4 months of age. 
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URETHRAL VALVES AND RENAL TRANSPLANTATION 
Chronic renal failure necessitates renal transplantation in a 
significant number of boys with PUV. With appropriate 
management, many patients with moderate renal insufficiency at 
birth reach adolescence before requiring transplantation. Modern 
studies have addressed the possible detrimental effects of the 
valve bladder on renal graft survival. Reinberg and colleagues48 
demonstrated significantly poorer 5-year graft survival for patients 
undergoing transplantation for valve-related renal failure than was 
found in those patients with nonobstructive etiologies. Similarly, 
Dewan and associates  reported that valve bladder led to allograft 
failure in 12% of valve patients receiving a renal transplant.  
 
Other authors have demonstrated good allograft survival but 
elevated creatinine levels occurring over long-term follow-up   in 
transplanted valve patients. A large study with 10-year follow-up 
after renal transplantation demonstrated no difference in graft 
survival and creatinine levels when comparing children with PUV 
and children with nonobstructive causes of renal failure. These 
data may reflect the improvement in urologic management of valve 
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bladder. The conclusion that the valve bladder will not negatively 
affect renal allografts is not supported by a long- term follow-up 
evaluation addressing bladder function and outcomes of renal 
transplantation. Salomon and coworkers reviewed the voiding 
history of 44 valve patients who were monitored for a mean of 9 
years after renal transplantation.  
 
They found an elevation of serum creatinine after 5 years of 
follow-up in boys with symptoms of bladder dysfunction including 
incontinence, urinary urgency, frequency, and difficulty emptying. 
Because of the relentless effects of the bladder on the upper 
tracts, the preservation of bladder function must be of primary 
consideration in all patients with PUV as management decisions 
are made. 
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DISCUSSION 
 
Our study included 52 patients of posterior urethral valves. 
Out of the 52 patients, 13 patients were in the new born period 
(25%) and 25 patients were infants (59%). The duration of follow 
ranged from 1 year to 5 years.  
 
On comparing our study with same Cohort of study group by 
All India Institute of Medical Sciences, Delhi (M.Bajpai et al), the 
most common age group at age group at initial presentation is in 
infants. 
 
Among the 38 patients with PUV, elevated serum creatinine 
value i.e., more than 0.8 mg/dl was present in 10 infants (34%) 
whereas in new born 6 of 13 babies had elevated serum creatinine 
level. In the 1 to 4 years of age group, elevated value is present in 
4 out of 8 cases.  
 
The most common initial procedure after stabilization of 
patients with posterior urethral valve was primary cystoscopic 
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valve ablation which was carried out in 82% of patients. (43 
cases). 
The remaining patients underwent diversion procedures 
either vesicostomy (6 patients) or cutaneous uretrostomy (3 
patients). Although we have preformed more number of diversion 
procedures before 2004, with the availability of new born 
cystoscope we presently perform primary valve ablation in all 
cases except in few patients.  
     In few centers like AIIMS, are started doing primary laser 
vaporization of valves even in the neonatal period but we are not 
having that facility at present.  
 
The percentage of patients who underwent primary valve 
ablation was highest in the new born period. (80%). Out of the 52 
patients, we did primary valve ablation in 43 cases.  
 
If the patient is not fit for the primary valve ablation either due 
to urosepsis or poor general condition we went for diversion 
procedures. 9 cases underwent diversion procedures either 
vesicostomy or bilateral uretrostomy. Among the 9 patients, 3 were 
below 1 year of age group, and rests of the patients were above 1 
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year of age group. Considering this scenario, primary valve 
ablation is ideal, if the diagnosis of PUV at the earlier age group.  
  
On the initial evaluation, 20 out of 52 patients, had elevated f 
serum creatinine (>1.2 mg/dl) level. Out of the 20 patients, 10 had 
normal creatinine level i.e., <0.8 mg/dl at the age of 12 months and 
maintain  within <1 mg/dl in the followup period. 2 patients had 
expired due to urosepsis and chronic renal failure. 8 patients had 
renal insufficiency in the regular follow up. Among the 8 patients, 4 
of them had vesico uretric reflux and renal scars in DMSA scan. 
 
Considering this, serum creatinine value at the initial 
evaluation, at the age of 1 year and the final follow up in an 
individual prognostic factor that determines the outcome of 
the PUV in our group.  
 
In this observation most of the patients in neonatal age group 
had renal failure at initial presentation, but one half of them had 
regained  normal renal function by the time of followup. In patients 
with 1 to 4 years of age group, the incidence of renal failure at 
present was similar (11 out of 21 patients) but the recovery was 
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not liked early presentation.  7 patients had renal insufficiency in 
the followup period.   
 
So early age at presentation is another good prognostic 
indicator in our observation.  
 
Out of 9 patients who underwent diversion procedures 
initially,6 patients had improved and their renal function regained 
to normal in 2 years followup , even though they undergone 
various secondary surgical procedure like bladder augmentation, 
Mitrofanoff’s procedure etc., So the treatment modalities either 
primary valve ablation or diversion  procedure does not affect the 
outcome of disease process in our study group.  
 
During the initial evaluation with ultra sonogram, 11 patients 
had sonographically identifiable abnormalities in kidneys and 
bladder (absence of cortico medullary differentiation, increased 
echogenecity of kindey and thickend bladder). Out of the 11 
patients 7 had chronic renal failure in the follow-up period, 3 of 
them expired, 1 patient had lost  to follow-up, probably expired.  
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So increased echogenecity of kidneys comparing with 
adjacent liver or spleen and absence of cartico medullary 
differentiation is a bad prognostic indicator in our 
observation. 
The presence of pressure Pop Off mechanisms like VURD, 
Patent urachus, urinary ascitis, bladder diverticuulum are 
considered to be a good prognostic factors for various texts. But in 
our study it’s not like so. We had 12 patients with pressure pop off 
mechanisms (7 VURD , 1 patent urachus and 4 bladder 
diverticulum). Out of the 12 patients 7 had renal insufficiency in the 
follow ups. It was probably due to late presentation. (All these 
patients were presented above 1 year) 
 
So the presence of pressure pop off does not alter the 
long term outcome of disease in our observation.  
 
Presence of vesico uretric reflux (18 patients) also did not 
affect the long term outcome.  
 
Only few numbers of PUV patients (7 out of 52) diagnosed 
antenatally in our group. Among the 7 patients we had lost 4 
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patients. (Either expired or lost to follow-up).Only 3 patients came 
for treatment and they underwent primary valve ablation. Out of 
the 3 patients, 1 patient expired in the follow up period.  
 
So the prognosis of antenatally detected cases of PUV in 
our centre is dismal.  
 
Considering the outcome of primary valve ablation, out of the 
43 patients, 6 had residual valves in the follow-up period, who 
needed residual valve ablation. In the remaining patients urinary 
stream became normal. All these patients are fully continent in the 
follow-up.  
 
Seven of our patients needed secondary surgical procedures 
like bladder augmentation, ureteric reimplantation, ureterocele 
excision etc., All these patients are in regular follow-up and 3 of 
them had renal insufficiency.  
 
Presence of 1 or more renal scars in DMSA scan signifies 
that the kidney would go for a progressive failure later. 7 of the 
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patients had renal scars initially and all these patients had renal 
failure on further follow-up.  
 
During the follow-up period of 5 years, 5 of our patients had 
expired due to chronic renal failure and urosepsis.  
Among the 52 patients 12 patients had chronic renal failure 
and they are now in regular nephrological followp.  
 
Recurrent urinary tract infection had present in 10 of our 
patients post operatively posing a great challenge to treat and it is 
mainly due to presence of high grade reflux.  
 
Considering all these observations only 18 of our patients 
(34%) had good continence and no renal insufficiency in the 5 
years follow-up and had a good quality of life.  
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Various described prognostic factors in the literature 
Variable Good Predictors Poor Predictors 
In – utero presentation 
(Weeks) 
>24 <24 
Amniotic fluid volume 
Normal to 
moderately 
increased 
Moderate to severely 
decreased 
Sonographic appearance of 
renal parenchyma 
Normal to slightly 
increased 
echogenicity 
Increased 
echogenicity to 
frankly cystic 
Fetal urinary values 
Sodium (mEq/L) 
Chloride (mEq/L) 
Osmolality (mOsm) 
Urinary output (ml/Hr) 
Beta 2 microglobulin 
 
<100 
<90 
<210 
>2 
<6 
 
>100 
>90 
>210 
<2 
>6 
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Prognostic variables – after birth 
Variable Good Predictors Poor Predictors 
Sonographic identification of 
CMJ differentiation 
Present  
Pyramids in atleast 
one kidney 
Absent 
Hyperechoic, no 
pyramids 
S.Crreatinine < 0.8 at one year  > 0.8 at one year 
Reflux No reflux Bilateral reflux 
Continence  At 5 years Incontinence 
Pop off mechanisms  
Urinary Ascites 
Bladder diverticulum VURD] 
Patent urachus 
Present 
Present 
Present 
Present 
Absent 
Absent 
Absent 
Absent 
 
In our study, only less number of patients are turned up 
antenataly  so the antenatal assessment of prognosis is difficult. 
So most of the patients were assessed postnatally with available 
investigations and clinical examinations.  
 
Indian Scenario of PUV 
The incidence of antenatal diagnosis is only 10%in India. 
Urinary diversion is done in 50% of cases in most centers, in 
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tertiary centres 80% of cases are ablated primarily. The results of 
laser fulguration of valves from AIMS, New Delhi and the primary 
newborn fulguration from other centers in India are encouraging. 
Abraham from Kerala, Gopal from Varanasi and Kulasekar from 
Colombo have developed hooks for valve ablation but the use is 
limited to their own centers only. Fetal surgery is not done in any of 
our tertiary centers. 
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CONCLUSION 
 
Early age group (<1 month) at initial presentation is a single 
most prognostic indicator in our observation. 
 
Serum creatinine level at the time of diagnosis, 12 months 
after valve ablation and at the time of last followup is the main 
factor that indicates the outcome of the disease. 
 
The treatment modalities either primary valve ablation or 
diversion procedures such as vesicostomy or cutaneous 
ureterostomy does not affect the outcome of disease process.  
 
The prognosis of our antenatally detected PUV patients were 
dismal 
 
Absence of corticomedullary differentiation and altered 
cortical echos in ultrasonography predict the poor prognostic 
outcome. 
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Presence of vesicoureteric reflux does not have any impact 
in the long term outcome.  
 
Presence of pressure pop of does not have any significance 
in our observation.  
 
Presence of one or more renal scars in DMSA scan is a 
definitive predictor for future renal impairment. 
 
Only 34% of our patients had good quality of life without 
renal insufficiency in the 5 year follow-up.  
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PROFORMA 
 
 
POSTERIOR URETHRAL VALVE – FOLLOW - UP  
 
 
 
Name     Age 
 
IP No.     PS No. 
 
Wt      Height 
 
Age at diagnosis    Age at surgical internvetion 
 
Antenatal USG 
 
Urine albumin 
 
Urine Culture 
 
Bl  Urea     Sr.Creatinine 
 
Sr Electrolytes    Na+    K+ 
 
Postnatal Ultrasound 
 
MCU – Bladder 
 
 Reflux Rt 
  
Lt 
 
Primary Procedure  
 
Post  op stream – good/fair/poor 
 
P/a Bladder 
 
 
 
FOLLOW UP 
 
 
Wt 
 
Urine alb 
 
Sp. Gravity 
 
Sr Electrolytes    Na+    K+ 
 
Bl Urea     Sr Cretinine 
 
Urine culture 
 
MCU 
 
Ultrasound 
 
Crystoscopy 
 
Urodynamics 
 
DMSA 
 
Procedure 
MASTER CHART 
Sl. 
No. Name Age 
Serum  
creatinine 
Level  
at Initial 
presentation 
Treatment 
1 B/o Chitra 17 days <0.8 Primary valve ablation 
2 Harish 3 months 2.1 Primary valve ablation 
3 Lavan Kishore 2 months 1.4 Primary valve ablation 
4 B/o Kalaiselvi 14 days 0.8 Primary valve ablation 
5 Kingisly Josuva 4.5 months 0.7 Primary valve ablation 
6 Sathish 7 months 1.6 Primary valve ablation 
7 Hariharan 1/2 year 2.2 Primary valve ablation 
8 Ashok Kumar 8 months 0.7 Primary valve ablation 
9 Dinesh 9 months 0.8 Primary valve ablation 
10 Lingamurthy  2 year 1.7 Diversion 
11 Akash 2 year 2 Primary valve ablation 
12 B/o Saraswathy 22 days 0.6 Primary valve ablation 
13 B/o Nagaswari 26 days 2 Primary valve ablation 
14 Vinnarasan 10 months 2.2 Diversion 
15 B/o Ramanathan 15 days 0.8 Primary valve ablation 
16 B/o Megala 3 months 0.7 Primary valve ablation 
17 B/o Divya 12 days 0.6 Primary valve ablation 
18 B/o Ranjitha 2 months 1.8 Primary valve ablation 
19 Nandakumar 2 year 0.8 Diversion 
20 Gopalakrishnan 4 year 2.3 Diversion 
21 B/o Shanthi 1.5 months 0.8 Primary valve ablation 
22 B/o Kavitha 19 days 0.6 Diversion 
23 B/o Sangeetha 4 months 0.7 Primary valve ablation 
24 B/o Mariyammal 3 months 0.8 Primary valve ablation 
25 Thoufiq 12 months 0.7 Primary valve ablation 
26 B/o Sumathi 7 months 0.9 Primary valve ablation 
 Sl. 
No. Name Age 
Serum  
creatinine 
Level  
at Initial 
presentation 
Treatment 
27 Sakthivel 11 months 0.8 Primary valve ablation 
28 B/o Sudha 6 months 0.7 Primary valve ablation 
29 Ranjith Kumar 2 year 1 Primary valve ablation 
30 B/o Saranya 12 days 0.6 Primary valve ablation 
31 B/o Vanitha 10 days 0.7 Primary valve ablation 
32 Prasanna 3 months 1.5 Diversion 
33 Johnson 7 months 0.7 Primary valve ablation 
34 Joas 2 year 2 Primary valve ablation 
35 B/o Kalyani 24 days 0.7 Diversion 
36 B/o Santhiya 7 days 0.8 Primary valve ablation 
37 Atheswaran  1.5 year 1.6 Primary valve ablation 
38 Mohamed Thoha 7 months 0.7 Primary valve ablation 
39 Sanjai 8 months 0.6 Primary valve ablation 
40 B/o Chitra 4.5 months 1.6 Primary valve ablation 
41 B/o Chandra  6 months 0.6 Primary valve ablation 
42 B/o Divya 6 days 0.8 Primary valve ablation 
43 Hariharan 1.5 year 1.1 Diversion 
44 B/o Mariyammal 27 days 1.6 Primary valve ablation 
45 B/o Anandi 3 months 1.2 Primary valve ablation 
46 Rama Krishnan 2 year 1 Diversion 
47 Santhosh Kumar 11 months 0.7 Primary valve ablation 
48 Adithiya 12 months <0.8 Primary valve ablation 
49 Akilesh 3 year 2 Primary valve ablation 
50 Rajeswaran  13 year 1.8 Primary valve ablation 
51 Kalaiyesan 2 year 1.5 Primary valve ablation 
52 Vasanth 2.5 year 1.2 Primary valve ablation 
 
